Artiria Medical Partners With Wyss Center to Accelerate Development of Cerebral Vasospasm Therapy

July 23, 2021—The Wyss Center and Artiria Medical SA announced their partnership to accelerate the translation of a novel technology that has the potential to reduce deaths and improve quality of life for stroke patients. The collaboration builds on Artiria Medical’s existing endovascular platform.

Artiria Medical, based in Lausanne, Switzerland, is an early-stage medical device company focused on the development of neurovascular products. The company’s next-generation technology is centered around a biocompatible expandable system to help safely deliver electrical energy into the targeted arteries using flexible thin-film electrodes. The technology aims to prevent arterial constriction following hemorrhagic stroke using an electroactive endovascular probe to interact with specific nerves from within the lower brain arteries to release arterial constriction across the entire brain.

The Wyss Center is an independent, nonprofit research and development organization focused on bioengineering and neuroengineering therapies based in Geneva, Switzerland. The Wyss Center partners with entrepreneurs to help accelerate devices from bench to market by contributing resources, expertise, and opportunities that influence the entrepreneurial process.

The partnership has received support from Innosuisse, the Swiss Innovation Agency, to test and validate the efficacy of the therapy preclinically, in preparation for human clinical studies.

Guillaume Petit-Pierre, CEO at Artiria Medical, commented in the announcement, “There is currently no truly effective solution that can treat cerebral vasospasm following hemorrhagic stroke, yet we know this is a leading cause of disability and death. We believe our technology has the potential to bring a new standard of care to patients and dramatically improve quality of life after stroke. Now, with the Wyss Center as our partner, we aim to have the technology ready for human trials as fast as possible.”

Wyss Center CEO Mary Tolikas, PhD, added, “The Wyss Center is excited to partner with Artiria Medical and help advance this innovative stroke treatment technology. Collaborating with driven entrepreneurs like the Artiria team is key to our mission to translate neuroscience innovations into clinical solutions.”